Trademark: 87166541
Status Date
Monday, November 13, 2017
Filing Date
Friday, September 9, 2016
Published for Opposition
Tuesday, February 14, 2017
Abandoned Date
Monday, November 13, 2017
9 Software for mobile devices for a diabetes support program that connects patients and caregivers to medical service providers and facilitates the exchange of medical data and medical advice; downloadable mobile application for medical and condition support for the treatment of diabetes; downloadable mobile application for medical professionals and medical patients featuring information relating to diabetes and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions; downloadable mobile application intended for diabetic patients for recording blood test results from a blood glucose monitor; software downloadable via the internet or downloadable mobile applications for monitoring and tracking blood glucose levels
10 Medical monitors for the detection, measurement and monitoring of physiological substances relating to diabetes, and parts and components thereof; blood glucose monitors; blood glucose monitors sold as a unit with blood glucose monitoring kits comprising strips for measuring blood glucose concentrations, lancets and control solution; medical equipment for monitoring diabetes, namely, sensors for measuring blood glucose levels, sensors for biotechnology applications, apparatus for measuring dosages and delivering pharmaceuticals, and apparatus for drawing or sampling blood or other bodily fluids; injectable insulin pens sold empty; insulin pumps for medical use sold empty; blood monitoring apparatus
38 Transmission of digital files; transmission of information and images via wireless communication networks regarding healthcare; transmission of information for others in the field of healthcare; transmission of information addressed to patients or healthcare professionals via wireless communication networks; transmission of information and images relating to pharmaceuticals and medicine via all means of telecommunication including the Internet and wireless communication networks; transmission of information via electronic communication networks and wireless communication networks; transmission of information in the field of diabetes; radio broadcasting service; provision of online forums and electronic bulletin boards for the transmission of messages among computer users in the pharmaceutical, medical, and healthcare fields; provision of internet chat rooms
42 Software as a services (SAAS) featuring software for mobile devices for a diabetes support program that connects patients and caregivers to medical service providers and facilitates the exchange of medical data and medical advice; software as a services (SAAS) featuring software for mobile devices for medical professionals and medical patients for purposes of monitoring blood glucose levels and for purposes of facilitating the exchange of medical data and medical advice for the treatment of diabetes; software as a services (SAAS) featuring software for mobile devices for medical professionals and medical patients featuring information relating to diabetes and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions
44 Provision of medical and condition support for the treatment of diabetes, by way of a mobile application; provision of medical information for doctors, patients, and caregivers in the field of diabetes; provision of medical and pharmaceutical health care information and advice in the field of diabetes; health care consulting in the field of diabetes; disease management programs in the field of diabetes; provision of medical information and educational information in the field of healthcare; health care services; medical consultation; disease management programs concerning healthcare; provision of medical information via the Internet; provision of health and pharmaceutical health care information
Nov 13, 2017
Abandonment Notice Mailed - No Use Statement Filed
Nov 13, 2017
Abandonment - No Use Statement Filed
Apr 11, 2017
Noa E-Mailed - Sou Required From Applicant
Apr 5, 2017
Review Of Correspondence Complete - Address Updated
Jan 31, 2017
Correspondence Received In Law Office
Feb 14, 2017
Official Gazette Publication Confirmation E-Mailed
Feb 14, 2017
Published For Opposition
Jan 25, 2017
Notification Of Notice Of Publication E-Mailed
Jan 9, 2017
Law Office Publication Review Completed
Dec 16, 2016
Approved For Pub - Principal Register
Dec 16, 2016
Examiner's Amendment Entered
Dec 16, 2016
Notification Of Examiners Amendment E-Mailed
Dec 16, 2016
Examiners Amendment E-Mailed
Dec 16, 2016
Examiners Amendment -Written
Dec 15, 2016
Assigned To Examiner
Sep 30, 2016
Applicant Amendment Prior To Examination - Entered
Sep 22, 2016
Assigned To Lie
Sep 14, 2016
New Application Office Supplied Data Entered In Tram
Sep 13, 2016
Teas Voluntary Amendment Received
Sep 13, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
